125 related articles for article (PubMed ID: 6287295)
1. Unique cell lines harbouring both Epstein-Barr virus and adult T-cell leukaemia virus, established from leukaemia patients.
Yamamoto N; Matsumoto T; Koyanagi Y; Tanaka Y; Hinuma Y
Nature; 1982 Sep; 299(5881):367-9. PubMed ID: 6287295
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human B-cell lines harbouring both adult T-cell leukaemia (ATL) virus and Epstein-Barr virus derived from ATL patients.
Koyanagi Y; Yamamoto N; Kobayashi N; Hirai K; Konishi H; Takeuchi K; Tanaka Y; Hatanaka M; Hinuma Y
J Gen Virol; 1984 Oct; 65 ( Pt 10)():1781-9. PubMed ID: 6092523
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-specific antibodies in patients with adult T-cell leukemia (ATL) and healthy ATL virus-carriers.
Imai J; Hinuma Y
Int J Cancer; 1983 Feb; 31(2):197-200. PubMed ID: 6298126
[TBL] [Abstract][Full Text] [Related]
4. Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines.
Tatsumi E; Harada S; Kuszynski C; Volsky D; Minowada J; Purtilo DT
Leuk Res; 1985; 9(2):231-8. PubMed ID: 2985880
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of adult T-cell leukemia virus-containing B-cell lines derived from peripheral blood of adult T-cell leukemia patients.
Miyamoto K; Tomita N; Ishii A; Nishizaki T; Togawa A
Gan; 1984 Aug; 75(8):655-9. PubMed ID: 6092185
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus susceptibility of B cells correlates to the presence of complement receptors but not surface immunoglobulins.
Takada K; Osato T
Intervirology; 1981; 16(2):118-22. PubMed ID: 6276327
[TBL] [Abstract][Full Text] [Related]
7. Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma.
Shimoyama M; Minato K; Tobinai K; Nagai M; Setoya T; Takenaka T; Ishihara K; Watanabe S; Hoshino H; Miwa M; Kinoshita M; Okabe S; Fukushima N; Inada N
Jpn J Clin Oncol; 1983; 13 Suppl 2():165-87. PubMed ID: 6603526
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
Sculley TB; Spelsberg TC; Pearson GR
Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
[TBL] [Abstract][Full Text] [Related]
9. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
Kwon KW
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
[TBL] [Abstract][Full Text] [Related]
10. Electron microscopic study of cell lines established from adult T-cell leukemia--coexistence of adult T-cell leukemia virus and Epstein-Barr virus.
Hirose Y; Shimizu S; Takiguchi T; Sugai S; Konda S
Jpn J Clin Oncol; 1984 Dec; 14(4):585-93. PubMed ID: 6097707
[TBL] [Abstract][Full Text] [Related]
11. In vitro infection of human B lymphocytes with adult T-cell leukemia virus.
Okada M; Koyanagi Y; Kobayashi N; Tanaka Y; Nakai M; Sano K; Takeuchi K; Hinuma Y; Hatanaka M; Yamamoto N
Cancer Lett; 1984 Feb; 22(1):11-21. PubMed ID: 6321019
[TBL] [Abstract][Full Text] [Related]
12. [Biology of adult T-cell leukemia virus].
Yamamoto N
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):674-9. PubMed ID: 6603822
[TBL] [Abstract][Full Text] [Related]
13. Virus production and surface marker expression in human lymphocytes immortalized following dual infection with human T-cell leukemia virus and Epstein-Barr virus.
Mochizuki S; Kawamura K; Maruyama K
Int J Cancer; 1986 Apr; 37(4):551-6. PubMed ID: 3007374
[TBL] [Abstract][Full Text] [Related]
14. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.
Hinuma Y; Komoda H; Chosa T; Kondo T; Kohakura M; Takenaka T; Kikuchi M; Ichimaru M; Yunoki K; Sato I; Matsuo R; Takiuchi Y; Uchino H; Hanaoka M
Int J Cancer; 1982 Jun; 29(6):631-5. PubMed ID: 6980846
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
17. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
18. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
19. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
20. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
